JUPITER-02 trial: advancing survival for recurrent metastatic nasopharyngeal carcinoma and next steps. Cancer communications (London, England) Tan, L. L., Le, Q., Lee, N. Y., Chua, M. L. 1800

View details for DOI 10.1002/cac2.12248

View details for PubMedID 34918497